Michael Andrew Schemick Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Michael Andrew Schemick has an estimated net worth of at least $18.2 million*, as of Dec. 18, 2024. They own 522,895 shares of CERT stock. They have sold 400,000 shares of CERT stock since 2021, for an estimated $12.1 million.
Michael Andrew Schemick $CERT SEC Form 4 Insider Trading
Michael Andrew Schemick has filed a total of 11 insider trades in $CERT since 2021. Their most recent trade was a purchase of 25,000 shares, made on Aug 17, 2022. Their largest trade was a sale of 66,667 shares, made on Jul 19, 2021. We estimate that they now own 522,895 shares of $CERT, worth an estimated $6.0 million.
Insider Trading at $CERT
There have been a total of 140 insider trades reported at $CERT since 2021, with 50,000 shares purchased and 70.7 million shares sold. The most active insider traders in $CERT stock have been William F Feehery, Richard M. Traynor, and Michael Andrew Schemick. The most recent trade was a sale of 5,409 shares reported by PATRICK F SMITH (PRESIDENT, DRUG DEV SOLUTIONS), made on Oct 07, 2024.
History of Insider Stock Trades by Michael Andrew Schemick
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
CERT | Purchase | 25,000 | Aug 17, 2022 | Aug. 18, 2022, 5:17 p.m. |
CERT | Sale | 770 | Nov 15, 2021 | Nov. 15, 2021, 8 p.m. |
CERT | Sale | 65,896 | Nov 15, 2021 | Nov. 15, 2021, 8 p.m. |
CERT | Sale | 4,618 | Oct 18, 2021 | Oct. 18, 2021, 8 p.m. |
CERT | Sale | 62,049 | Oct 18, 2021 | Oct. 18, 2021, 8 p.m. |
CERT | Sale | 18,570 | Sep 20, 2021 | Sept. 20, 2021, 8 p.m. |
CERT | Sale | 48,097 | Sep 20, 2021 | Sept. 20, 2021, 8 p.m. |
CERT | Sale | 65,267 | Aug 16, 2021 | Aug. 16, 2021, 8 p.m. |
CERT | Sale | 1,400 | Aug 16, 2021 | Aug. 16, 2021, 8 p.m. |
CERT | Sale | 66,667 | Jul 19, 2021 | July 20, 2021, 8 p.m. |
CERT | Sale | 66,666 | Jun 22, 2021 | June 22, 2021, 8 p.m. |
$CERT Executives and Stock Owners with Insider Trades
-
William F Feehery, CHIEF EXECUTIVE OFFICER
-
Richard M. Traynor, SVP AND GENERAL COUNSEL
-
Michael Andrew Schemick, CHIEF FINANCIAL OFFICER
-
Jieun W. Choe, CHIEF STRATEGY & MARKETING
-
Robert Aspbury, PRESIDENT, SIMCYP
-
Justin Edge, PRES., REGULATORY & ACCESS
-
Patrick F Smith, PRESIDENT, DRUG DEV SOLUTIONS
-
Craig R. Rayner, PRESIDENT, INTEGRATED DRUG DEV
-
Leif E Pedersen, PRESIDENT, SOFTWARE
-
Patrick F Smith, PRESIDENT, INTEGRATED DRUG DEV
-
Leif E Pedersen, PRESIDENT, CHIEF COMMERCAL OFF
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.